Cangrelor
Cangrelor (AR-C69931MX), an adenosine triphosphate analogue, is an intravenous, reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor directly blocks adenosine diphosphate (ADP) -induced activation and aggregation of platelets. Cangrelor is also a nonspecific GPR17 antagonist[1][2].
Product Specifications
CAS Number
163706-06-7
Product Name Alternative
AR-C69931MX
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cangrelor.html
Solubility
10 mM in DMSO
Smiles
CSCCNC1=C2C(N([C@H]3[C@H](O)[C@H](O)[C@@H](COP(OP(C(Cl)(Cl)P(O)(O)=O)(O)=O)(O)=O)O3)C=N2)=NC(SCCC(F)(F)F)=N1
Molecular Formula
C17H25Cl2F3N5O12P3S2
Molecular Weight
776.36
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
P2Y12 Receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human Complement Factor B Protein
